|
End-of-day quote
Shanghai S.E.
18/08/2026
|
5-day change | 1st Jan Change | ||
| 17.91 CNY | +0.79% |
|
-1.76% | +1.65% |
| 24/04 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 24/04 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.79% | -1.76% | -3.55% | -4.78% | +1.65% | +5.11% | -37.86% | -45.90% | - | 300.21Cr | ||
| -1.58% | -3.94% | +3.44% | -14.75% | -30.63% | -37.14% | -18.60% | -45.62% | - | 1.59TCr | ||
| -0.76% | -11.07% | -3.12% | -23.23% | -35.54% | -38.93% | -32.89% | -72.32% | -40.60% | 675.84Cr | ||
| +0.40% | -2.70% | -1.76% | +8.55% | -8.28% | -22.70% | -16.28% | +51.22% | +219.94% | 611.53Cr | ||
| 0.00% | +2.43% | +15.22% | +4.21% | +10.50% | +2.70% | -25.81% | -24.11% | +112.09% | 431.64Cr | ||
| -0.05% | -3.48% | +2.20% | -5.25% | -2.16% | -19.87% | -40.26% | - | - | 322.02Cr | ||
| -0.67% | -3.16% | -8.79% | -15.98% | -37.85% | -44.22% | -23.79% | -28.58% | +61.78% | 302.59Cr | ||
| -1.05% | -0.99% | +0.43% | -3.98% | -15.66% | -13.81% | -3.13% | +38.81% | +121.44% | 264.33Cr | ||
| +0.74% | -7.69% | -5.53% | +4.56% | +27.22% | +62.07% | - | - | - | 240.7Cr | ||
| -0.03% | 0.00% | -6.86% | -18.95% | -14.31% | -8.01% | +27.51% | -6.69% | - | 158.83Cr | ||
| -2.63% | +1.62% | -6.75% | +34.12% | -3.46% | -32.20% | -43.78% | -53.10% | - | 153.87Cr | ||
| -0.26% | +1.05% | +2.12% | +3.21% | +35.48% | +53.42% | +98.05% | +231.08% | +305.37% | 118.44Cr | ||
| -0.03% | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -8.31% | +4.92% | 114.04Cr | ||
| -1.84% | -0.09% | +3.62% | -9.28% | -8.79% | -21.64% | -51.93% | -63.08% | -49.87% | 101.78Cr | ||
| -1.78% | +4.60% | +14.02% | -10.28% | -10.61% | +12.32% | -32.12% | - | - | 100.22Cr | ||
| -1.08% | +1.53% | -5.90% | -17.84% | -22.69% | -42.89% | -59.81% | - | - | 88Cr | ||
| -1.08% | -0.29% | +12.24% | +2.46% | -6.78% | +6.75% | -37.27% | -34.34% | - | 84Cr | ||
| +1.27% | -3.13% | -17.01% | -30.09% | -17.65% | -18.30% | -26.35% | - | - | 82Cr | ||
| +0.83% | +0.76% | -7.80% | -1.48% | -20.52% | -34.35% | - | - | - | 80Cr | ||
| +1.84% | +3.45% | -4.64% | -0.69% | -27.52% | -24.24% | +43.23% | +64.72% | - | 68Cr | ||
| Average | -0.35% | -1.56% | -0.92% | -4.97% | -9.38% | -10.80% | -15.62% | +0.27% | +91.88% | 294.41Cr | |
| Weighted average by Cap. | -0.61% | -2.87% | +0.45% | -7.37% | -15.39% | -19.54% | -20.15% | -20.19% | +90.79% |
- Stock Market
- Stocks
- 603233 Stock
- Sector DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















